Vicore Pharma Holding AB, unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists, announced it has entered into an exclusive licensing agreement with Nippon Shinyaku Co. Ltd., a leading Japanese pharmaceutical company, to develop and commercialize Vicore’s drug candidate C21 in Japan.
BioInvent International AB announced a clinical supply agreement with AstraZeneca to evaluate BioInvent’s anti-FcyRIIB antibody, BI-1206, in combination with rituximab and Calquence®, in a Phase 1/2a study in non-Hodgkin’s lymphoma.
BioInvent to Evaluate BI-1206 in Combination with Rituximab and Calquence Read More »
Las estrellas variables nos brindan una ventana única para comprender los procesos fundamentales que ocurren en el cosmos. Desde estrellas pulsantes hasta explosiones cataclísmicas, cada tipo de estrella variable tiene su propia historia que contar. 1. Estrellas Variables Intr …
¿Qué tipos diferentes de estrellas variables existen? Read More »
Las plagas de langostas han sido una preocupación constante para la agricultura a lo largo de la historia, pero en los últimos años han resurgido con una intensidad y frecuencia alarmantes. Estos voraces insectos pueden diezmar cosechas enteras en cuestión de horas, dejan …
Sensorion announced a €50.5 million offering reserved to specific categories of investors through the issuance of 88,594,737 new ordinary shares of the Company at a price per New Share of €0.57 to the benefit of Redmile Group, Invus and Sofinnova Partners, existing shareholders, and leading US Healthcare Specialists funds including Aquilo Capital, as well as
En la era digital actual, la Internet de las Cosas (IoT) ha emergido como una fuerza transformadora que está redefiniendo la forma en que interactuamos con el mundo que nos rodea. Desde hogares inteligentes hasta ciudades conectadas, la IoT está integrando la tecnología en todos …
Metagenomi, Inc. (Nasdaq: MGX) (“Metagenomi”), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived gene editing toolbox, today announced the pricing of its initial public offering of 6,250,000 shares of its common stock at a price to the public of $15.00 per share.
Metagenomi Announces Pricing of Initial Public Offering Read More »
The Dallas-based provider told investors on Thursday that ambulatory surgeries would drive a greater portion of its profits moving forward.
Tenet says its upcoming ‘new era’ will be fueled by ambulatory surgeries Read More »
HHS task force ambassador Ty Greenhalgh discusses what the Biden administration’s cybersecurity performance goals mean for the industry, and how they could lead to a tightening of the HIPAA Security Rule.
The job cuts, expected by March 12, include senior management positions, scientists and engineers.
Illumina to lay off 111 people at San Diego headquarters Read More »
